Navigation Links
New Garlic Product Mimics Garlic to Perfection

Clinical trials have come up with novel methods to study 'better than nature' methods to study the effects of a commercial// garlic product in maintaining a healthy cardiovascular system without the typical side effects of using raw garlic.

A recent study presented at the Annual Meeting of the American College of Nutrition today reveals that amounts equal to that of fresh high allicin garlic macerate can be delivered to the body by a new proprietary garlic product developed by Nutra Products, Inc., Garli-Eze?. Allicin, is the chief bioactive ingredient of garlic. It was established in the study that all untoward effects of chewing fresh garlic were avoided when using this new garlic propriety product.

By nature a very short lived bioactive substance, allicin requires complicated and highly sophisticated methods to assess its presence in a product. A method developed by Dr. Larry Lawson, a world renowned garlic researcher, was used in the study the results of which was published as a decisive research article in 2005 in the Journal of Agricultural and Food Chemistry. . This method employs a highly sensitive method of analyzing the breath after ingestion of garlic and unequivocally can determine if garlic was both delivered to the body for absorption, and its subsequent absorption.

Dr. Rick Falkenberg, Chief Technical Officer of Nutra Products Inc., the maker of Garli-Eze?, "Allicin is the only known key biologically active compound of fresh crushed garlic. We believe a high level of allicin delivered directly to the gastrointestinal tract is a key to helping maintain a healthy cardiovascular system. This preliminary human study indicates that Garli-Eze? can deliver large amounts of allicin directly to the upper gastrointestinal tract where it can be easily absorbed. Using innovative state-of-the-art manufacturing we have developed a process that delivers as much natural allicin as fresh garlic without offensive odors or discomf
'"/>




Page: 1 2

Related medicine news :

1. More to Garlic than warding of Dracula
2. Garlic a day keeps cancer away
3. Garlic fights malaria and cancer
4. Garlic Supplements Impede HIV Therapy
5. Vegetables And Garlic Confer Protection From Skin Cancer
6. Another Feather In The Garlic Cap: Helpful In Avoiding Breast Cancer
7. Garlic inhibits fungal growth and protects food
8. Garlic Helps To Reduce Cholesterol in Rats
9. Garlic compound may help treat cancer
10. Onions, Garlic may Reduce the Risk of Cancer
11. Garlic may Not Aid in Heart Disease and Cholesterol Levels
Post Your Comments:
(Date:5/16/2008)...R, Minn., May 16 /PRNewswire-USNewswire/ -- This r...Mayo Clinic in conjunction with the,National Cance...udy being presented at the American Society of Cli..., may change treatment practice,in about 25 percen...or,proposed changes to the way colorectal cancers ...
(Date:5/16/2008)... Covers More than 500 Workers, WASHINGTON, May 16...cs,and emergency medical technicians in the Greate...have ratified their first-ever contract as,Teamste...s are now covered by a,strong contract that gives ...," said Teamsters General President Jim Hoffa., T...
(Date:5/16/2008)...rom an international, multicenter Phase III clinic...therapy everolimus (RAD001) significantly delays c...ey cancer whose disease had worsened on other trea...n attending physician at Memorial Sloan-Kettering ...gs on May 31 at the annual meeting of the American...
(Date:5/16/2008)...n) Declaring that Primary care medicine is in a p...dent of the American College of Physicians (ACP), ...oyers and consumers to issue a call for comprehens... internists and other primary care physicians. ,...y care medicine in the U.S., Dr. Dale and other pa...
Breaking Medicine News(10 mins):Health News:New Method Proposed for Determining Which Patients Should Get Treatment for Colorectal Cancer 2Health News:Drug fends off kidney cancer progression 2Health News:ACP says major system reforms needed to improve the state of primary care medicine in the US 2
...revent, a powdered medication inhaled by asthma pa...us of an FDA Pulmonary-Allergy Drugs Advisory Comm...aths related to asthmatic symptoms in patients who...FDA documents released yesterday indicate that abo...
...ase III clinical trial of Ruboxistaurin (RBX) at a... inhibit Protein kinase C (PKC) – beta inhibitor, ...ith diabetes. The study was conducted in 252 pat...the Research team of Joslin Diabetes Centre across...
...e incidence of asthma, hay fever or any of the all...f brain cancer that may be fatal. Variations in ce...ore prone to the attacks of asthma and other aller...ns also prevent the incidence of the most common f...
... interesting study done in Nepal and India has sho...stoves is associated with increased risk of develo...ct has been found to be widely prevalent in develo... present study examined the association between co...
Other Medicine News:
(Date:5/15/2008)...BRIDGEWATER, N.J., May 15 /...ounced today that findings from the,landmark ATHEN...l therapy,for the treatment of patients with atria...sk of cardiovascular hospitalizations or death fro...0.00000002), meeting the study,primary endpoint. T...
(Date:5/15/2008)...BOSTON, May 15 /- CenterWatch, a publ... market research about clinical,trials, finds that...e EDC,(electronic data capture) systems. More than... indicated that they had been trained on three or ...d that the effectiveness of,their EDC training had...
(Date:5/15/2008)...care Advantage Fee-For-Service Plan Positions Blue...iness, According to a New Report from ...enn., May 15 /- HealthLeaders-InterSt...ntelligence, reports that as the,economy continues...f,Michigan remains the best equipped of all of its...
(Date:5/15/2008)...GREEN BAY, Wis., May 15 /- Omega 3 fa...rther considered as a credible natural,alternative...ADHD patients,recent in vivo French study reveals...ffects of omega-3 in hyperactivity, French researc...e specific positive effects on,impulse control., ...
Breaking Medicine Technology:Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation 2Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation 3Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation 4Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation 5Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation 6Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation 7CenterWatch Releases State of the Clinical Trials Industry 2008 - A Key Industry Resource for Market Research and Competitive Intelligence 2Blue Cross Blue Shield Of Michigan Battles Sluggish Economy With Diverse Product Lineup 2Omega 3 Fatty Acids Bound to Phospholipids has Potential Benefit for Attention-Deficit Hyperactivity Disorder (ADHD) 2Omega 3 Fatty Acids Bound to Phospholipids has Potential Benefit for Attention-Deficit Hyperactivity Disorder (ADHD) 3Congenital heart defects increasing among IVF twins 10631 1Congenital heart defects increasing among IVF twins 10631 2Max Nutrition Inc Completes Share Exchange with American Spring Pharmaceutical Inc 2906 1Max Nutrition Inc Completes Share Exchange with American Spring Pharmaceutical Inc 2906 2Pennsylvania Governor Rendell Announces 241 8 Million Investment to Add Nurses Improve Nurse Education Grants Awarded to Recipients in 28 Counties 10627 1Pennsylvania Governor Rendell Announces 241 8 Million Investment to Add Nurses Improve Nurse Education Grants Awarded to Recipients in 28 Counties 10627 2Pennsylvania Governor Rendell Announces 241 8 Million Investment to Add Nurses Improve Nurse Education Grants Awarded to Recipients in 28 Counties 10627 3Pennsylvania Governor Rendell Announces 241 8 Million Investment to Add Nurses Improve Nurse Education Grants Awarded to Recipients in 28 Counties 10627 4Halogen Advances its Lead in Providing Employee Performance and Talent Management Solutions for the Healthcare Market 2904 1Halogen Advances its Lead in Providing Employee Performance and Talent Management Solutions for the Healthcare Market 2904 2
...INNEAPOLIS--(BUSINESS WIRE)--Mar 26, 2007 - Two-ye...III trial confirm the positive,clinical profile of...ring to nearly 1,300 the number of Endeavor patien...ficantly, among those 1,300,Endeavor patients, the...bosis using the independent, pre-specified clinica...
... Company Set to Host Evening Symposium at ATC -,...nced today that,an independent data monitoring c...data from the Phase 2b kidney transplant (PROMISE)...proximately 1/3 of,the anticipated 332 patients ... trial continue according to the original study,...
Other Medicine Technology:Two-Year Results from the Medtronic ENDEAVOR III Trial Confirm,Stent's Positive Clinical Profile 2Two-Year Results from the Medtronic ENDEAVOR III Trial Confirm,Stent's Positive Clinical Profile 3Isotechnika's independent data monitoring committee conducts review,of phase 2b kidney transplant trial 2Isotechnika's independent data monitoring committee conducts review,of phase 2b kidney transplant trial 3Isotechnika's independent data monitoring committee conducts review,of phase 2b kidney transplant trial 4
This handheld reference is a practical guide to established surgical oncology principles for each organ system.
The Editors and Contributors are a virtual "Who's Who" in surgery, and they have prepared an outstanding program that provides expert advice on a full range of problems. Destined to be the "gold stan
The First Aid for the Surgery Clerkship is designed to prepare for the surgery clerkship examination and provides clinical diagnosis and treatment of many of the problems seen by surgeons.
CURRENT Consult: Surgery brings you authoritative clinical answers on more than 360 surgically treated disorders in the most efficient format, perfectly devised for the busy physician.
Medicine Products: